CAPLIPOINT

Caplin Point Laboratories Share Price

 

 

Invest in Caplin Point Laboratories with 3.02X leverage

Invest with MTF

Performance

  • Low
  • ₹1,747
  • High
  • ₹1,886
  • 52 Week Low
  • ₹1,599
  • 52 Week High
  • ₹2,626
  • Open Price₹1,882
  • Previous Close₹1,894
  • Volume597,777

Investment Returns

  • Over 1 Month -6.66%
  • Over 3 Month -11.28%
  • Over 6 Month -14.42%
  • Over 1 Year -31.41%

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.1
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 13,611
  • P/B Ratio
  • 4.3
  • Average True Range
  • 47.75
  • EPS
  • 77.46
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -6.25
  • RSI
  • 42.21
  • MFI
  • 37.85

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹1,790.70
-102.9 (-5.43%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,935.58
  • 50 Day
  • ₹1,963.32
  • 100 Day
  • ₹2,001.00
  • 200 Day
  • ₹2,005.96

Resistance and Support

1900.27 Pivot Speed
  • R3 1,973.73
  • R2 1,951.47
  • R1 1,922.53
  • S1 1,871.33
  • S2 1,849.07
  • S3 1,820.13

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories is a rapidly growing pharmaceutical company with a strong presence in Latin America, Francophone Africa, and expanding into regulated markets like the USA and EU. it specializes in manufacturing and distributing a wide range of pharmaceutical products.

Caplin Point Labs. has an operating revenue of Rs. 2,039.67 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 35% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-05 Quarterly Results
2025-08-07 Quarterly Results, Final Dividend & A.G.M.
2025-05-15 Audited Results & Interim Dividend
2025-02-07 Quarterly Results
2024-11-07 Quarterly Results
Date Purpose Remarks
2025-09-12 FINAL Rs.3.00 per share(150%)Final Dividend
2025-05-30 INTERIM Rs.3.00 per share(150%)Interim Dividend
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
View Caplin Point Laboratories Dividend History Arrow

Caplin Point Laboratories F&O

Caplin Point Laboratories Shareholding Pattern

70.57%
1.79%
0.23%
6.51%
0%
14.2%
6.7%

About Caplin Point Laboratories

  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • Managing Director
  • Dr. Sridhar Ganesan
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹1,790 As on 30 December, 2025 | 15:41

The Market Cap of Caplin Point Laboratories is ₹13611.4 Cr As on 30 December, 2025 | 15:41

The P/E ratio of Caplin Point Laboratories is 23.1 As on 30 December, 2025 | 15:41

The PB ratio of Caplin Point Laboratories is 4.3 As on 30 December, 2025 | 15:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23